Skip to content Skip to footer
Recarbrio: Benefits, Reviews, Info, Side Effects!
Rx Details
Recarbrio
Imipenem/cilastatin/relebactam, MK-7655
Imipenem/cilastatin/relebactam
Prescription
Antibiotic
Drugs
Prescription Only
broad-spectrum antibiotic, treats bacterial infections, effective against resistant strains, combination of imipenem, cilastatin, and relebactam, used for complicated urinary tract infections, used for complicated intra-abdominal infections, used for hospital-acquired bacterial pneumonia, administered intravenously, generally well-tolerated, potential option for multidrug-resistant infections
Anemia, Diarrhea, Elevated Blood Pressure, Fever, Headache, Hypokalemia, Increased Liver Enzymes, Infusion Site Reactions, Nausea, Rash
Recarbrio is a combination antibiotic used to treat certain serious infections. It consists of imipenem, cilastatin, and relebactam. The dosage of Recarbrio can vary based on the type and severity of the infection, as well as patient-specific factors such as kidney function. The typical dosage for adults with normal renal function is 1.25 grams (imipenem 500 mg, cilastatin 500 mg, and relebactam 250 mg) administered intravenously every 6 hours. However, the dosage may need to be adjusted for patients with renal impairment. It’s important to follow the prescribing healthcare provider’s instructions and the guidelines provided in the prescribing information for the most accurate and safe dosage. Always consult a healthcare professional for medical advice tailored to individual needs.
Bacterial infections, complicated urinary tract infections, complicated intra-abdominal infections, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia
Recarbrio has a generally safe safety profile.
No Interactions Reported
$1,500 – $2,000
$3000

A Synopsis of

Recarbrio

Recarbrio is a powerful antibiotic medication that combines three active ingredients – imipenem, cilastatin, and relebactam. This combination is specifically designed to treat serious bacterial infections in patients who have limited treatment options. Imipenem works by inhibiting the growth of bacteria, while cilastatin helps to prevent the breakdown of imipenem in the kidneys. Relebactam is a beta-lactamase inhibitor that helps to enhance the effectiveness of imipenem against certain resistant bacteria.

This medication is typically used to treat complicated urinary tract infections, including pyelonephritis, as well as complicated intra-abdominal infections. It is important to note that Recarbrio should only be used when other antibiotics have failed or are not suitable for the patient’s condition. It is not intended for use in mild or moderate infections that can be treated with less potent antibiotics.

As with any medication, there are potential side effects associated with Recarbrio. These may include nausea, diarrhea, headache, and allergic reactions. It is important to discuss any concerns or potential side effects with your healthcare provider before starting this medication.

It is crucial to take Recarbrio exactly as prescribed by your healthcare provider to ensure the best possible outcome. Do not skip doses or stop taking the medication early, even if you start to feel better. This can lead to the development of antibiotic-resistant bacteria and make future infections more difficult to treat.

If you have any questions or concerns about Recarbrio or your treatment plan, do not hesitate to reach out to your healthcare provider. Your health and well-being are our top priorities, and we are here to support you every step of the way.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN